CCS
PAHC icon

Crosspoint Capital Strategies’s Phibro Animal Health PAHC Stock Holding History

Crosspoint Capital Strategies’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-177
Closed -$6K – 675
2014
Q4 		$6K Buy
+177
New +$4.89K ﹤0.01% 565

Other funds holding PAHC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
PIM
Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
DIA
Denver Investment Advisors Denver, Colorado $1.89B AUM 7.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Crosspoint Capital Strategies's PAHC Position: Q1 2015 in Review

Crosspoint Capital Strategies sold out of Phibro Animal Health (PAHC) in Q1 2015, closing a stake of 177 shares — an estimated $6K sold.

Crosspoint Capital Strategies first reported a position in PAHC in Q4 2014 and held it in 1 quarter. The position peaked at $6K in Q4 2014. 108 funds tracked by Wall St. Rank hold PAHC as of Q1 2015.

  • Crosspoint Capital Strategies reported no remaining Phibro Animal Health position as of Q1 2015 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 177 Phibro Animal Health shares in Q1 2015, an estimated $6K.
  • Crosspoint Capital Strategies first reported a position in Phibro Animal Health in Q4 2014 and held it in 1 quarter.
  • Crosspoint Capital Strategies's Phibro Animal Health position peaked at $6K in Q4 2014.
  • 108 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2015.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2015, filed 18 May 2015.